Basiliximab widens the therapeutic window for AUC-monitored neoral therapy early after kidney transplantation
To access this article, please choose from the options below
PII: S0041-1345(03)00868-6
doi:10.1016/j.transproceed.2003.08.005
© 2003 Elsevier Science Inc. All rights reserved.
